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Resum.	Robert edwards és el pare de les tècniques de re­
producció assistida. Gràcies a ell, han nascut al món més de 
quatre milions de criatures que, possiblement, no existirien si 
no hagués estat pel desenvolupament d’aquestes tècniques. 
La fecundació in vitro, inicialment una tècnica concebuda per 
a superar determinades malalties que provoquen esterilitat 
femenina, va obrir la porta a tot un seguit de noves tecnologi­
es associades que, pel fet de posar al nostre abast els gàme­
tes i els embrions humans, han permès interaccionar amb 
aquestes entitats biològiques de la nostra pròpia espècie i 
modificar conceptes que fins aleshores teníem molt clars i 
immutables: la maternitat, les relacions paternofilials, el co­
mençament de la vida o, fins i tot, la pròpia identitat humana. 
Amb aquests canvis, o més ben dit darrere seu, han vingut 
un seguit de modificacions en els valors ètics i els conceptes 
legals que els acompanyen que han significat una autèntica 
revolució en la visió que tenim de nosaltres mateixos com a 
espècie i el lloc que ocupem en l’immens panorama de la 
natura.
paraules	clau: tècniques de reproducció assistida ∙ bioètica ∙ 
fertilització in vitro
Abstract.	Robert Edwards is the father of assisted reproduc­
tion techniques. Thanks to him, more than 4 million children 
have been born who possibly would have not existed had it not 
been for the development of these techniques. In vitro fertiliza­
tion, a technique originally designed to overcome certain dis­
eases that cause female sterility, opened the door to a whole 
series of new, associated technologies that, by putting at our 
disposal human gametes and embryos, have allowed us to in­
teract with these biological entities of our own species in addi­
tion to modifying the concepts that, until that moment, had 
very clear and constant meanings: maternity, paterno­filial rela­
tionships, the beginning of life, and even human identity itself. 
These changes as well as those that followed resulted in a re­
assessment of our ethical values and legal concepts, which in 
turn has caused a genuine revolution in the way we view both 
ourselves as a species and the place we occupy in the vast 
panorama of nature.
Key	words:	assisted reproduction techniques ∙ bioethics ∙ in 
vitro fertilization
According to Alfred Nobel’s will, the Nobel Prize was to be 
granted to “those who, during the preceding year, shall have 
conferred the greatest benefit on mankind.” It is very unusual 
that Nobel’s laureates receive their award the year after their 
discovery or invention—the most recent exception being Presi­
dent Obama, winner of the 2009 Peace Prize, who was so sur­
prised by the announcement as to be slightly embarrassed. In­
deed, the subject of this talk had to wait for 32 years to see his 
work acknowledged. In the interval between Edwards’ discov­
ery and his Nobel Prize (Fig. 1), Louise Brown, the first baby 
born after the successful application of in vitro fertilization (IVF), 
grew up and had a child of her own (Cameron, spontaneously 
conceived), while Patrick Steptoe, Edward’s colleague in IVF 
development, died in 1988 and thus never received the full ac­
knowledgement he obviously deserved. 
The Nobel Prizes 2010
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Fig.	1. Robert G. Edwards.	Photo: Copy­
right © Bourn Hall
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Why	the	delay?
But what are the reasons for the long delay between a Nobel­
worthy contribution and its award? In my opinion, there are 
several reasons:
•  A general bias in the Nobel Prizes themselves
•  Intense opposition to this particular award
•  Fear regarding the decision
It is generally accepted that Nobel Prizes tend to favor dis­
coveries over inventions or theories. An example of this asser­
tion is the fact that in 1921 Albert Einstein was awarded the 
Prize for his discovery of the photoelectric effect, not for his 
theory of relativity. The development of a new therapy, such as 
IVF, can be considered more an invention than a discovery; this 
general bias would lessen its chances of receiving the Nobel 
Prize allowing new and interesting discoveries to move up the 
eligibility list.
A	furious	opposition.	The work of Dr. Edwards had, from the 
very beginning, colossal opponents and detractors. Suffice to 
say that the same day the Nobel Prizes were publicly commu­
nicated, a press release from the Vatican appeared in mass 
media all over the world. It criticized the awarding of the Nobel 
Prize to Dr. Edwards, based on the fact that it failed to take into 
account “the ethical implications of such an award” and it reit­
erated that IVF “is unacceptable since it implies the selection 
and the elimination of human embryos”. The Vatican’s position 
is clearly stated in the document ‘Instruction Dignitas Personae 
on certain Bioethical questions’ from the Congregation for the 
Doctrine of the Faith, which said (sic.):
“With regard to the treatment of infertility, new medical 
techniques must respect three fundamental goods: a) the 
right to life and to physical integrity of every human being 
from conception to natural death; b) the unity of marriage, 
which means reciprocal respect for the right within mar­
riage to become a father or mother only together with the 
other spouse; c) the specifically human values of sexuality 
which require ‘that the procreation of a human person be 
brought about as the fruit of the conjugal act specific to the 
love between spouses.’ Techniques which assist procrea­
tion are not to be rejected on the grounds that they are ar­
tificial. As such, they bear witness to the possibilities of the 
art of medicine. But they must be given a moral evaluation 
in reference to the dignity of the human person, who is 
called to realize his vocation from God to the gift of love 




This statement is undoubtedly in favor of maintaining the 
boundary between sexuality and reproduction which, as dis­
cussed below, IVF and related techniques have clearly disman­
tled.
Fear	regarding	the	decision.	The ethical and social implica­
tions of IVF and related assisted reproductive techniques (ARTs) 
make them provocative topics. A social revolution was aroused 
after the development of ARTs because they implied a new 
perception of the position of our own species in the context of 
the world. This can be envisaged as a threat but also as an op­
portunity for the evolution of mankind; and it is discussed later 
in this article as something positive. However, recognition of 
the controversy that the decision would likely arouse no doubt 
led to an unusual delay in the Nobel Prize being granted to Ed­
wards (and Steptoe).
Reasons	for	an	acknowledgement
In my opinion, and surely that of the Nobel Prize Award Com­
mittee, there were many important reasons for recognizing Dr. 
Edwards’ contribution to medicine in general and to the treat­
ment of infertility in particular:
•  Traditional interest in reproduction
•  The associated improvements in our understanding of re­
production 
•  As the basis for many other related technologies
•  For its efficiency
•  In setting the stage for a social revolution
Traditional	interest	in	reproduction. Human reproduction 
has been a topic of fascination throughout our history. At the 
beginning of human civilization, this fascination became a reli­
gious matter, with fertility and related agrarian cults offering us 
some of the oldest human representations ever found. Images 
such as Willendorf’s Venus (dated between 24,000 and 
21,000 BC) and the Paleolithic Levantine paintings at Cogul’s 
Cave (between 10,000 and 6500 BC) are examples of art in 
which male and female sexual characters are explicitly depict­
ed and even exaggerated. Later, already in historic eras, fertil­
ity cults, such as those of the Min, Heqet, and Taweret in an­
cient Egypt, and Priapus and Cybele in ancient Greece and 
Rome, were related to agrarian and resurrection cults. During 
the Renaissance, this curiosity becomes more ‘scientific,’ as 
evidenced by Leonardo da Vinci’s interest in the anatomy of a 
fetus inside the womb or the anatomy of sexual intercourse. 
Attention then moves to more cellular aspects, with published 
depictions of a spermatozoon under the microscope, the so 
called homunculus [12], or the ovum as the origin of everything 
(Ex ovo omnia) [13]. 
Associated	 improvements	 in	our	understanding	of	 re-
production. Sir Isaac Newton famously remarked, “If I have 
seen further, it is by standing on the shoulders of giants.” No 
new discovery or technology appears from nowhere; rather, 
previous to any advance in human knowledge there are other 
works and fundamental steps that pave the way for the new 
discovery. This was the case for the 2010 Nobel Prize in 
Physiology or Medicine. A quick review of these steps is as 
follows.
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1890   First ‘surrogate mother.’ Walter Heape reports the trans­
fer of rabbit embryos to a hare’s uterus, resulting in two 
pups.
1932   Aldous Huxley imagines IVF in his novel Brave New 
World.
1946  William J. Hamilton and John A. Laing describe the de­
velopment of cow eggs until the blastocyst stage [10].
1951  Collin R. Austin identifies the need for sperm capacita­
tion in mammals before fertilization [1].
1952	 	Robert G. Edwards starts his PhD. 
1953   James D. Watson and Francis H.C. Crick determine the 
structure of DNA [23]. 
1955  Robert G. Edwards defends his PhD: ‘Growth of mouse 
embryos with altered chromosome complements,” di­
rected by Alan Beatty.
1959	 	Min Chueh Chang reports the first rabbits to be conceived 
by IVF; however, sperm capacitation took place in vivo [4].
1963  Ryuzo Yanagimachi and Min Chueh Chang report suc­
cessful IVF in hamsters, with every step of the process 
performed in vitro [25].
1970  Robert G. Edwards and co­workers perform the first hu­
man IVF using oocytes matured in Vivo [7].
1971   They obtain good quality human embryos in all pre­im­
plantation stages. Later, Robert G. Edwards will remem­
ber:
   “I’ll never forget the day I looked down the micro­
scope and what I saw was a human blastocyst gazing 
up at me. I thought: We’ve done it!”
1972	 	Edwards and co­workers begin embryo transfers at 
Newmarket Hospital. The Medical Research Council de­
nies them financial support:
   “The Board accepted that Dr. Edwards was an inves­
tigator of high scientific standing, energy and originality. 
Board members and referees, however, all had serious 
doubts about the ethical aspects of the proposed inves­
tigations, especially those relating to the implantation in 
women of oocytes fertilized in vitro, which was consid­
ered premature in view of the lack of preliminary studies 
on primates and the present deficiency of detailed 
knowledge of the possible hazards involved. Reserva­
tions were also expressed about the procedure of lapar­
oscopy for purely experimental purposes, and about the 
proposed facilities and arrangements for patient care. 
Recommendations: 
    (i) The application should be declined on ethical 
grounds and the reason should be conveyed to Dr. 
Edwards and Mr. Steptoe.
    (ii) It should be suggested, without commitment, to 
Dr. Edwards that he might formulate an application to 
the Council for support of a similar programme of 
work on primates.”
  Robert Edwards remembers: 
   “Steptoe and I were deeply affected by the despera­
tion felt by couples who so wanted to have children. We 
had a lot of critics but we fought like hell for our patients. 
But we had enough supporters—not many—but just 
enough for us to carry on our work.” [2]
1973  An Australian team of Dr. Carl Wood’s [6] achieves the 
first human pregnancy after IVF, but it ends as a sponta­
neous abortion.
1975   Edwards’ team, using gonadotrophins to induce super­
ovulation, successfully induces a pregnancy after trans­
ferring blastocysts, but it is ectopic and thus terminated 
after 10 weeks of gestation.
1977  The researchers decide to move towards natural, un­
stimulated cycles. On 10 November 1977, they treat a 
woman with tubal infertility using a single fertilized oocyte 
that, after transfer at the 8­cell stage, results in the birth 
of Louise Brown on 25 July 1978 [19] (Fig. 2, 3A).
   After this first success, three more pregnancies were 
obtained; two of them ended as miscarriages, one be­
cause a triploid fetus; the second due to a complication 
of amniocentesis, which revealed a normal 46XY fetus. 
The third resulted in the birth of Alistair.
1984   Victoria Anna, the first Spanish baby conceived by IVF, 
was born; the infertility treatment had been performed at 
the Institut Universitari Dexeus in Barcelona (Fig 3B). 
This first birth in Spain led to a close and fruitful relation­
ship between Robert Edwards and several Spanish sci­
entists. At that time, Edwards, together with Jean Cohen, 
was establishing a new scientific society, the European 
Society of Human Reproduction and Embryology (ES­
HRE) dedicated to basic knowledge on the biology of re­
production as well as clinical aspects of human infertility 
and ARTs. They were joined by Dr. Josep Egozcue, from 
the Autonomous University of Barcelona, and Dr. Pere N. 
Barri, from the Institut Universitari Dexeus among other 
scientist from most European countries.
   This relationship would last throughout the public ca­
reer of Dr. Robert Edwards and would allow two of them 
(Dr. Josep Egozcue and Dr. Anna Veiga) to succeed him 
Fig.	3. A) Dr. Robert Edwards holding Louise Brown after her birth. B) 
Dr. Gloria Calderon holds in her arms Victoria­Anna after her birth.
Fig.	2.	 An example of the media 
coverage of the birth of Louise 
Brown, which made the covers of 
many newspapers. 
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as Presidents of ESHRE (Fig. 4). The contribution of Rob­
ert Edwards to our basic understanding of mammalian 
reproduction is certainly noteworthy but his contribution 
to infertility treatments was groundbreaking, since IVF 
was followed by a long list of closely related ARTs.
“A new field of medicine has emerged, with Robert Edwards 
leading the process all the way from the fundamental discoveries 
to the current, successful IVF therapy. His contributions repre­
sent a milestone in the development of modern medicine.” [9]
As	the	basis	for	many	other	related	technologies.	 In an 
editorial by the ESHRE, it was pointed out that Robert Ed­
wards’ work provided the basis for other ARTs that would initi­
ate a new discipline in the field of Medicine: Reproductive Med­
icine and even Regenerative Medicine. Let us review their 
primary focuses.
In vitro fertilization. IVF is based on a very simple principle: to 
join spermatozoa and oocytes outside a woman’s body. To do 
so, the gametes must first be collected and then appropriately 
prepared. Collecting oocytes ready to be fertilized is one of the 
major handicaps of this technique. The procedure starts by 
suppressing the woman’s hormonal pituitary levels and induc­
ing a rise in FSH (follicle stimulating hormone) and LH (luteiniz­
ing hormone) by injecting these hormones according to a 
complex and personalized protocol. This procedure induces 
superovulation, yielding a higher than normal number of 
oocytes to be fertilized and, most importantly, controlled ovula­
tion. The oocyte is removed by an echo­guided follicle punc­
ture, which is followed by a short period of in vitro culture to al­
low the female gamete to reach the adequate degree of 
maturation. Spermatozoa are obtained by masturbation fol­
lowed by centrifugation of the semen to remove the seminal 
plasma, thereby inducing sperm capacitation. Gametes can 
come from the two members of the couple or from gamete 
donors, if one or even both members cannot produce them. 
Once the male and female gametes are obtained, they are 
incubated together in an appropriate in vitro environment for 
several hours until signs of fertilization are observed: two pro­
nuclei and two polar bodies. These embryos are then cultured 
in vitro for 3 to 5 days after which they are transferred to the 
uterus, either that of the female member of the couple or that of 
a surrogate mother. The introduction of donors in the repro­
ductive project has changed our notions regarding parent­
hood, as is discussed later on in this article.
Gamete and embryo freezing. Although the first pregnancy 
generated from frozen sperm dates back to 1954 [3], in 1984 
the first success in freezing human embryos was described 
[26] while it was not until 1997 that oocyte freezing became 
possible [16]. Freezing gametes and embryos requires their 
maintenance at very low temperatures in liquid nitrogen 
(−196°C), which prevents all biochemical reactions. Cryopro­
tectants must be added to the freezing medium in order to 
avoid ice formation, as this would damage cellular structures. 
Under these conditions cells can safely be stored almost in­
definitely. The ability to freeze gametes and embryos has led to 
the creation of banks that facilitate both the preservation of fer­
tility, even after the donor’s death and donation. The first fro­
zen­thawed embryo successfully resulting in a pregnancy in 
Spain was in 1986 [21], a noteworthy event since only one cell 
survived after thawing. 
Pre-implantation genetic diagnosis. Pre­implantation genetic 
diagnosis (PGD) was developed in 1989 by Handyside and 
coworkers [11] in order to select normal in vitro fertilized em­
bryos before transferring them to the uterus in couples at high 
risk of having a child with genetic abnormalities. In Spain, PGD 
was first clinically used in 1993, making it the third case de­
scribed in the world [22]. PGD requires the removal of a single 
cell from a 6­ to 8­cell embryo and then genetically character­
izing it by fluorescent in situ hybridization (FISH) or polymerase 
chain reaction (PCR) DNA amplification. However, the indica­
tions for PGD have expanded since its initiation and now in­
clude the selection of embryos for analysis based on other cri­
teria, such as avoiding the transmission of a genetic disease to 
future generations [18], selecting against embryos carrying 
genes that predispose the future adult to developing some 
kinds of cancer (breast or colon cancers), selecting healthy 
embryos that will be compatible donors for siblings affected by 
genetic diseases (human leukocyte antigen [HLA] matching), or 
even selecting the embryo of the desired sex for social reasons 
(social sexing).
Intracytoplasmic sperm injection (ICSI). First reported in 1992 
[15], ICSI consists of injecting the sperm into the oocyte’s cyto­
plasm using a micromanipulator. Either ejaculated spermatozoa 
with low fertilizing capacity (as in oligo­, astheno­, terato­
zoospermia) or sperm obtained from the epidydimis, deferent 
ducts, or even testis can be used. ICSI also can be performed, 
although with lower fertilization efficiencies, using round or elon­
gated spermatides [8]. This versatility in the origin of the male 
Fig.	 4. Dr. Edwards and Dr. Egozcue 
(top row, second and sixth from left to 
right, respectively) among other ESHRE 
Presidents [2]. (B) Dr. Anna Veiga, Dr. 
Pere N. Barri and Dr. Edwards at a dinner 
during the 2007 ESHRE Meeting, held in 
Lyon.
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gametic material has made it a powerful technique capable of 
overcoming a wide variety of infertility problems of male origin.
Regenerative medicine. Regenerative medicine is based on the 
use of a very special type of cells: stem cells. Their undifferenti­
ated state makes them pluripotent, i.e., they can differentiate 
into any kind of cells of the organism from which they were de­
rived, in order to regenerate damaged tissues and organs from 
individuals (regenerative medicine). Stem cells can be obtained 
from adult cells either directly (adult stem cells) or by inducing 
their pluripotentiality (induced pluripotent stem cells, iPS) [20]. 
The use of cells from either source does not cause any ethical 
concern but some of their biological characteristics make them 
unsuitable for certain regenerative processes. By contrast, 
stem cells derived from human embryos (embryonic stem cells, 
ESC), prepared as described above but not used further, have 
the capacity to differentiate into any kind of cell and seem to be 
suitable for regenerative medicine, but their use has raised eth­
ical concerns.
One of the most serious drawbacks faced by regenerative 
medicine is immunological rejection. To solve this problem, self­
transplant has been proposed, implying the use of cells derived 
from the same adult organism (iPS) or of cloning technologies 
(somatic cell nuclear transfer, SCNT) to derive genetically identi­
cal ESC, in what has been called therapeutic cloning. SCNT 
technology was developed to produce transgenic animals and 
resulted in the birth of the first mammalian clone, a sheep called 
Dolly, in 1996 [24]. It consists of removing the genetic material of 
a recipient oocyte and replacing it with the nucleus of a donor 
somatic cell. After that, the reconstructed embryo is activated to 
initiate embryonic development, leading to either an individual 
(reproductive cloning) or ESC (therapeutic cloning).
Finally, there is a line of investigation exploring the possibility 
of obtaining gametes, both male and female, from stem cells. 
Preliminary results from animal models have been encourag­
ing. If these attempts can be reproduced in humans, they could 
solve many infertility problems even among individuals who 
cannot produce gametes. 
For	its	efficiency.	The efficiency of the various ARTs are ex­
pressed as the pregnancy rate, which varies widely depending 
on the circumstances of the particular ART application but is 
typically between 20 and 50%. Comparing these figures with 
what is considered to be the efficiency of natural conceptions 
(33%) it is clear that, for those unable to conceive, these tech­
niques can offer the same chance of reproductive success as 
achieved by fertile individuals. Moreover, it has been estimated 
that, across the world, these techniques have resulted in the 
birth of over 4,300,000 babies since 1978. It seems obvious 
thatn in this sense, Robert Edwards’ work can be considered 
as ‘a great benefit to mankind.’
In	setting	the	stage	for	a	social	revolution. As mentioned 
above, the social revolution linked to the development of ARTs 
poses, in the opinion of some people, a threat whereas others 
see it as an opportunity. I belong to the latter group since I am 
convinced that the changes brought about by ARTs have for­
ever altered our vision of ourselves and the place we occupy in 
the vast panorama of nature.
Dissociation between sex and reproduction. This social revo­
lution is based on the complete dissociation between sex and 
reproduction. Of course, before the development of ARTs sex 
without reproduction was certainly possible, but there could 
be no reproduction without sex. This made maternity and vir­
ginity opposing concepts, a situation that conditioned many 
beliefs and even the history of Christian civilizations.
New paterno-filial relationships. By dissociating sex from repro­
duction, ARTs has changed our definition of paterno­filial rela­
tionships. These changes are concomitant with the appear­
ance of new kinds of maternity, brought about by ARTs. Before 
1978, there were only two kinds of ‘mothers’: legal and biologi­
cal. After 1978, the biological mother concept was split into 
gestational mother and genetic mother, since gestation could 
be carried out by a surrogate mother or by the recipient of a 
donated oocyte. Moreover, in late 1990s, the use of a tech­
nique in which part of the cytoplasm from oocytes obtained 
from young women was transferred to older women to improve 
their gestation capacity resulted in the birth of a dozen children 
[5]. Although this technique is no longer used due to unexpect­
ed side effects, it briefly introduced the concept of the ‘cyto­
plasmic’ mother, different from the genetic mother, since it pro­
vides mitochondrial DNA from the donor to the embryo. 
All these ‘new maternities’ can be exerted by the same per­
son or by different ones. Furthermore, these maternities (or pa­
ternities) can be exerted asynchronously, introducing leaps 
among generations: embryos being gestated by their nieces; 
embryos without parents but with grandparents, derived from 
gametes obtained from ESC (which in turn would have been 
obtained from an embryo that has never produced an individu­
al); embryos descended from siblings, which is essentially how 
clones must be considered since, from a biological point of 
view, they are like asynchronous homozygotic twins...
Providing a new step in human life. Before Edwards’ work, hu­
man life was generally defined as comprising three major phas­
es, fetal life, childhood and adulthood, but ARTs’ ability to ma­
nipulate the preimplantation embryo provided a possible fourth 
phase. Therefore new biological, ethical and legal questions 
arose: What is a human pre­implantation embryo? What moral 
consideration does it deserve? What rights does it have? As 
stated by John A. Robertson [17]:
“Precisely because the early embryo is genetically unique 
and has the potential to be more, it operates as a powerful 
symbol or reminder of the unique gift of human existence...”
for that reason
“While the preimplantation human embryo doesn’t have the 
same moral status as infants and children, it deserves spe­
cial respect and serious moral consideration as a developing 
form of human life.” [14] 
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Preimplantation human embryos do not have a moral status 
but they do have a moral value; thus, there are moral reasons 
to treat them in some ways and not in others. A situation simi­
lar, although not identical, as of how to treat a human corpse, 
since it also deserves special considerations. According to this 
line of reasoning, the human embryo is not considered as a 
person and thus it does not have an absolute value. Its moral 
value can be pounded by other values, i.e., health, research, 
and general wellbeing, such that it can and should be used 
only when morally relevant ends are sought.
This argument has inspired new laws, bylaws, and interna­
tional treaties among developed countries that seek to reflect 
these social changes in their legal codes. In Spain, the most 
important laws are 14/2006, on Human Assisted Reproduction 
Techniques, and 14/2007, on Biomedical Research. Among 
the international treaties, one of the most relevant is the Con­
vention on Human Rights and Biomedicine (Oviedo’s Conven­
tion), enacted by the Council of Europe on 4 April 1997. Based 
on all these considerations, the title I chose for this article: Rob-
ert Edwards. Changing the perception of our own nature, I 
guess is pertinent and has been sufficiently justified.
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